Sanofi drug gets EU panel backing for progressive multiple sclerosis
Tweet Send to a Friend
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Sanofi's (EURONEXT: SAN) (NASDAQ: SNY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


